A Phase 3b, open-label, single-arm, rollover study to evaluate long-term safety in subjects who have participated in other luspatercept (ACE-536) clinical trials

Project: Research project

Project Details

StatusActive
Effective start/end date4/27/208/31/50

Funding

  • Celgene Corporation
  • Celgene Corporation